دورية أكاديمية

Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events

التفاصيل البيبلوغرافية
العنوان: Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events
المؤلفون: Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vendula, Curik, Nikola, Laznicka, Adam, Krizkova, Jitka, Suttnar, Jiri, Klener, Pavel, Polakova, Katerina Machova
المصدر: In Molecular Metabolism October 2024 88
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22128778
DOI:10.1016/j.molmet.2024.102016